About: The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	The immunogenicity and reactogenicity of primary vaccination at 3, 4 and 5 months and boosting at 12-18 months with a new DTPw-HBV vaccine was compared with either licensed DTPw and HBV vaccines given separately or a licensed DTPw-HBV combination (Tritanrix-HepB) in this randomized, partially double-blind primary vaccination and single-blind booster vaccination study in healthy infants (n = 239; Trial DTPw-HBV-001/004). One month after primary vaccination with the new DTPw-HBV vaccine, seroprotection against diphtheria, tetanus, hepatitis B and vaccine response to B. pertussis was seen in 100%, 98.7%, 94.9% and 98.7% of subjects, respectively, compared to 100%, > or =98.5%, 89.2% and 92.2% of subjects in the comparator groups, respectively. The immunogenicity and reactogenicity of primary vaccination at 3, 4 and 5 months and boosting at 12-18 months with a new DTPw-HBV vaccine was compared with either licensed DTPw and HBV vaccines given separately or a licensed DTPw-HBV combination (Tritanrix-HepB) in this randomized, partially double-blind primary vaccination and single-blind booster vaccination study in healthy infants (n = 239; Trial DTPw-HBV-001/004). One month after primary vaccination with the new DTPw-HBV vaccine, seroprotection against diphtheria, tetanus, hepatitis B and vaccine response to B. pertussis was seen in 100%, 98.7%, 94.9% and 98.7% of subjects, respectively, compared to 100%, > or =98.5%, 89.2% and 92.2% of subjects in the comparator groups, respectively. (en) Imunogenita a reaktogenita primárního očkování ve 3., 4. a 5. měsíci a posilované dávky ve 12-18 měsících nové DTPw-HBV vakcíny ve srovnání s licencovanoui DZPw-HBV vakcínaou aplikovanou oddělneně nebo licencovanou DTPw-HBV kombinací (Tritanrix-HepB). V této randomizované, částečně dvojitě slepé primární očkovací a jednoduše zaslepené posilovací vakcinační studii u zdravých kojenců (n=239; Trial DTPw-HBV-001/004). Měsíc po základním očkování novou DTPw-HBV vakcínou bylasledována seroprotekce pro difeterii tetanu, hepatitidě B a proti pertussi ve 100 %, 98,7 %, 94,9 % a 98,7 % subjektů, respektive ve srovnání s kontrolní skupinou se 100 %, 98,5 %, 89,2% a 92,2 %. (cs)
Title	Imunogenicita a reaktogenita nové DTPw-HBV vakcíny v primárním a booster (cs) The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants (en)
skos:prefLabel	Imunogenicita a reaktogenita nové DTPw-HBV vakcíny v primárním a booster (cs) The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants (en)
skos:notation	RIV/60162694:G44__/07:00001864!RIV08-MO0-G44_____
http://linked.open.../vavai/riv/strany	121-126
http://linked.open...avai/riv/aktivita	Z
http://linked.open...avai/riv/aktivity	Z(MO0FVZ0000502)
http://linked.open...iv/cisloPeriodika	4
http://linked.open...vai/riv/dodaniDat	2008
http://linked.open...aciTvurceVysledku	Prymula, Roman
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ministerstvo obrany / Univerzita obrany - Fakulta vojenského zdravotnictví Hradec Králové
http://linked.open...dnocenehoVysledku	425523
http://linked.open...ai/riv/idVysledku	RIV/60162694:G44__/07:00001864
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	DTPw; combination paediatric vaccines; DTPw-HBV; diphtheria; tetanus; whole cell petussis; primary vaccination; booster vaccination (en)
http://linked.open.../riv/klicoveSlovo	DTPw booster vaccination combination paediatric vaccines primary vaccination whole cell petussis tetanus DTPw-HBV diphtheria
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[E66CCD5E3CDC]
http://linked.open...i/riv/nazevZdroje	Human Vaccines
http://linked.open...in/vavai/riv/obor	FN
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	5 (xsd:int)
http://linked.open...UplatneniVysledku	2007
http://linked.open...v/svazekPeriodika	3
http://linked.open...iv/tvurceVysledku	Prymula, Roman Kohl, Igor David, Marie-Pierre Lefevre, Inge Štefkovičová, Mária
http://linked.open...n/vavai/riv/zamer	Implementation of the new information of hygiene, preventive medicine and epidemiology into the military health care
issn	1554-8600
number of pages	6 (xsd:int)
http://localhost/t...ganizacniJednotka	G44

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software